Clinical Trial Update: Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating two doses of an oral live attenuated HRV vaccine in healthy infants reports on efficacy, immune response, and safety; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 2 | Status: COMPLETED